Browsing: Magazine

Bayer has announced that the U.S. Food and Drug Administration (FDA) approved Ambelvist (gadoquatrane), a new, intravenous macrocyclic gadolinium (Gd)-based contrast agent (mGBCA) indicated for contrast-enhanced magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in the central nervous system (CNS) and non-CNS body regions in adult and pediatric patients.

Subtle Medical has announced FDA clearance of SubtleHD(PET), its next-generation AI-powered PET image enhancement solution designed to improve image quality…